[go: up one dir, main page]

ZA200107716B - Disodium salts, monohydrates and ethanol solvates. - Google Patents

Disodium salts, monohydrates and ethanol solvates.

Info

Publication number
ZA200107716B
ZA200107716B ZA200107716A ZA200107716A ZA200107716B ZA 200107716 B ZA200107716 B ZA 200107716B ZA 200107716 A ZA200107716 A ZA 200107716A ZA 200107716 A ZA200107716 A ZA 200107716A ZA 200107716 B ZA200107716 B ZA 200107716B
Authority
ZA
South Africa
Prior art keywords
monohydrates
disodium salts
ethanol solvates
solvates
ethanol
Prior art date
Application number
ZA200107716A
Other languages
English (en)
Inventor
William E Bay
Rajesh K Agarwal
Kiran Chaudhary
Signai Majuru
Micheal M Goldberg
Joanne P Russo
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of ZA200107716B publication Critical patent/ZA200107716B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ZA200107716A 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates. ZA200107716B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12775499P 1999-04-05 1999-04-05

Publications (1)

Publication Number Publication Date
ZA200107716B true ZA200107716B (en) 2003-08-18

Family

ID=22431779

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200309114A ZA200309114B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.
ZA200107716A ZA200107716B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200309114A ZA200309114B (en) 1999-04-05 2001-09-18 Disodium salts, monohydrates and ethanol solvates.

Country Status (3)

Country Link
AU (1) AU4218400A (xx)
WO (1) WO2000059480A1 (xx)
ZA (2) ZA200309114B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
SI9720025A (sl) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CZ302280B6 (cs) 1998-08-07 2011-01-26 Emisphere Technologies, Inc. Slouceniny a prostredky pro dodávání aktivních látek
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU2001236457A1 (en) 2000-01-13 2001-07-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
NZ523017A (en) 2000-06-29 2004-10-29 Emisphere Tech Inc Compounds and compositions for delivering active agents and preparation method thereof
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
AR040737A1 (es) * 2002-08-01 2005-04-20 Novartis Ag Administracion oral de calcitonina
US9498487B2 (en) 2004-05-19 2016-11-22 Emisphere Technologies, Inc. Topical cromolyn formulations
RU2406504C2 (ru) 2004-05-19 2010-12-20 Эмисфире Текнолоджис, Инк. Способы изготовления лекарственных составов ацикловира
CA2591515C (en) 2004-12-29 2010-06-22 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
PL2131810T3 (pl) 2007-03-02 2011-09-30 Novartis Ag Podawanie doustne kalcytoniny
JP5985985B2 (ja) 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドEmisphere Technologies,Inc. 胃腸への影響が減少した即効型ナプロキセン組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient

Also Published As

Publication number Publication date
ZA200309114B (en) 2005-02-23
AU4218400A (en) 2000-10-23
WO2000059480A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA99254B (en) Benzosulfone derivatives.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
ZA9811339B (en) Benzamidine derivatives.
ZA200203834B (en) Adamantane derivatives.
ZA98362B (en) 3-heterocyclyl-substituted benzoyl derivatives.
ZA200107716B (en) Disodium salts, monohydrates and ethanol solvates.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA200201829B (en) New phenylpiperazines.
ZA978045B (en) New benzamidine derivatives.
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
ZA991550B (en) Cyclohexanediole derivatives.
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
ZA982436B (en) Thiazolimine derivatives.
MXPA01011285A (es) Derivados de tio-oxindol.
GB0029720D0 (en) I.S machine7544232001
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
ZA971167B (en) Heterocyclyl-ergoline derivatives.